Home > Financial Ratios > BAL PHARMA

BAL PHARMA
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Margin(%) 8.308.539.842.947.86

What is the latest Core EBITDA Margin ratio of BAL PHARMA ?

The latest Core EBITDA Margin ratio of BAL PHARMA is 8.30 based on Mar2023 Consolidated results.
Year Core EBITDA Margin
Mar20238.30
Mar20228.53
Mar20219.84
Mar20202.94
Mar20197.86

How is Core EBITDA Margin of BAL PHARMA Trending?

Years Core EBITDA Margin % Change
Mar2023 8.3
-2.70
Mar2022 8.53
-13.31
Mar2021 9.84
234.69
Mar2020 2.94
-62.60
Mar2019 7.86 -

Other Financial Ratios of BAL PHARMA


Compare Core EBITDA Margin ratio of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹155.8 Cr -1.7% -4.7% 23.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹358,305.0 Cr -1% -7.2% 56.8% Stock Analytics
CIPLA ₹109,709.0 Cr -4.6% -6.2% 49.8% Stock Analytics
DIVIS LABORATORIES ₹100,599.0 Cr -4.1% 1.1% 19.8% Stock Analytics
DR REDDYS LABORATORIES ₹98,073.3 Cr -7.4% -4.8% 22.7% Stock Analytics
ZYDUS LIFESCIENCES ₹97,383.3 Cr -2.9% -3.9% 94.8% Stock Analytics


BAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

-1.7%

-4.7%

23.7%

SENSEX

-3%

-2.5%

17.3%


You may also like the below Video Courses